Regeneron Pharmaceuticals
REGN
#320
Rank
A$109.99 B
Marketcap
A$1,068
Share price
0.94%
Change (1 day)
22.50%
Change (1 year)

Earnings for Regeneron Pharmaceuticals (REGN)

Earnings in 2026 (TTM): A$7.63 Billion

According to Regeneron Pharmaceuticals's latest financial reports the company's current earnings are A$15.53 Billion. In 2025 the company made an earning of A$7.48 Billion, an increase over its 2024 earnings that were of A$6.84 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Regeneron Pharmaceuticals from 1990 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$7.63 B2.02%
2025 A$7.48 B9.43%
2024 A$6.84 B13.83%
2023 A$6.00 B-13.57%
2022 A$6.95 B-47.9%
2021 A$13.34 B144.75%
2020 A$5.45 B56.86%
2019 A$3.47 B-4.87%
2018 A$3.65 B22.86%
2017 A$2.97 B56.3%
2016 A$1.90 B8.55%
2015 A$1.75 B54.53%
2014 A$1.13 B11.14%
2013 A$1.02 B72.13%
2012 A$0.59 B-285.93%
2011 -A$0.32 Billion121.73%
2010 -A$0.15 Billion37.18%
2009 -A$0.11 Billion-14.6%
2008 -A$0.13 Billion-25.02%
2007 -A$0.17 Billion6.32%
2006 -A$0.16 Billion-186.52%
2005 A$0.17 B2103.7%
2004 A$8.07 M-105.66%
2003 -A$0.15 Billion-18.18%
2002 -A$0.18 Billion42.33%
2001 -A$0.13 Billion129.35%
2000 -A$53.47 Million51.87%
1999 -A$35.21 Million92.19%
1998 -A$18.32 Million66.23%
1997 -A$11.02 Million-55.49%
1996 -A$24.76 Million103.53%
1995 -A$12.17 Million-70.89%
1994 -A$41.79 Million-26.08%
1993 -A$56.53 Million114.67%
1992 -A$26.34 Million196.77%
1991 -A$8.88 Million87.88%
1990 -A$4.73 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$37.50 B 407.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$22.21 B 200.46%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
A$14.72 B 99.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$10.24 B 38.60%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
A$1.44 B-80.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$1.60 B-78.23%๐Ÿ‡บ๐Ÿ‡ธ USA